Genetic testing at the time of diagnosis facilitates choice of treatment and BRCA1 carriers with breast cancer may benefit from bilateral mastectomy, from oophorectomy and from cisplatinum treatments [12, 13]. Here, BRCA1 is linked to breast carcinoma.